Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 11-Jun-24 9:02 PM View:  | Deciphera Pharmaceuticals, ... (NA) | 11-Jun-24 | Grant | 34,157 | -- | -- | 31% 110.13K to 144.29K | |
| 11-Jun-24 9:02 PM View: | Deciphera Pharmaceuticals, ... (NA) | 11-Jun-24 | Disposition | 72,029 | -- | -- | (50%) 144.29K to 72.26K | |
| 11-Jun-24 9:02 PM View: | Deciphera Pharmaceuticals, ... (NA) | 11-Jun-24 | Disposition (change in control) | 72,261 | -- | -- | (100%) 72.26K to 0 | |
| 20-Feb-24 4:06 PM View: | Deciphera Pharmaceuticals, ... (NA) | 16-Feb-24 | Sale | 2,615 | $15.62 | $40,840.30 | (2%) 111.35K to 108.74K | |
| 20-Feb-24 4:06 PM View: | Deciphera Pharmaceuticals, ... (NA) | 15-Feb-24 | Grant | 17,275 | -- | -- | 18% 94.08K to 111.35K | |
| 18-Jan-24 4:15 PM View: | Deciphera Pharmaceuticals, ... (NA) | 16-Jan-24 | Private Sale | 2,435 | $14.47 | $35,233.70 | (3%) 96.51K to 94.08K | |
| 14-Dec-23 4:05 PM View: | Deciphera Pharmaceuticals, ... (NA) | 13-Dec-23 | Sale | 2,792 | $15.37 | $42,904.90 | (3%) 99.31K to 96.51K | |
| 14-Dec-23 4:05 PM View: | Deciphera Pharmaceuticals, ... (NA) | 12-Dec-23 | Grant | 8,244 | -- | -- | 9% 91.06K to 99.31K | |
| 31-Oct-23 4:11 PM View: | Deciphera Pharmaceuticals, ... (NA) | 30-Oct-23 | Sale | 2,360 | $12.02 | $28,361.50 | (3%) 92.99K to 90.63K | |
| 31-Oct-23 4:11 PM View: | Deciphera Pharmaceuticals, ... (NA) | 28-Oct-23 | Grant | 8,244 | -- | -- | 10% 84.74K to 92.99K | |
| 04-Oct-23 4:05 PM View: | Deciphera Pharmaceuticals, ... (NA) | 02-Oct-23 | Private Sale | 2,942 | $12.68 | $37,304.60 | (3%) 87.69K to 84.74K | |
| 21-Jun-23 4:05 PM View: | Deciphera Pharmaceuticals, ... (NA) | 16-Jun-23 | Private Sale | 1,655 | $14.40 | $23,835.00 | (2%) 89.34K to 87.69K | |
| 17-Feb-23 4:07 PM View: | Deciphera Pharmaceuticals, ... (NA) | 16-Feb-23 | Sale | 971 | $15.10 | $14,661.10 | (1%) 89.12K to 88.14K | |
| 17-Feb-23 4:07 PM View: | Deciphera Pharmaceuticals, ... (NA) | 15-Feb-23 | Grant | 16,488 | -- | -- | 23% 72.63K to 89.12K | |
| 19-Jan-23 4:05 PM View: | Deciphera Pharmaceuticals, ... (NA) | 17-Jan-23 | Private Sale | 2,403 | $21.24 | $51,042.80 | (3%) 75.03K to 72.63K | |
| 05-Oct-22 4:05 PM View: | Deciphera Pharmaceuticals, ... (NA) | 03-Oct-22 | Private Sale | 2,587 | $18.73 | $48,454.50 | (3%) 76.88K to 74.3K | |
| 21-Jun-22 4:37 PM View: | Deciphera Pharmaceuticals, ... (NA) | 16-Jun-22 | Private Sale | 1,768 | $10.75 | $19,006.00 | (2%) 78.65K to 76.88K | |
| 18-Feb-22 5:01 PM View: | Deciphera Pharmaceuticals, ... (NA) | 16-Feb-22 | Market Sale | 984 | $9.05 | $8,905.20 | (1%) 77.77K to 76.79K | < 1% |
| 20-Jan-22 5:00 PM View: | Deciphera Pharmaceuticals, ... (NA) | 18-Jan-22 | Grant | 20,500 | -- | -- | 36% 57.27K to 77.77K | |
| 17-Dec-21 4:05 PM View: | Deciphera Pharmaceuticals, ... (NA) | 15-Dec-21 | Grant | 11,100 | -- | -- | 24% 46.17K to 57.27K | |
| 06-Oct-21 4:00 PM View: | Deciphera Pharmaceuticals, ... (NA) | 04-Oct-21 | Market Sale | 2,659 | $33.17 | $88,199.00 | (5%) 48.69K to 46.03K | 8% |
| 18-Feb-21 7:00 PM View: | Deciphera Pharmaceuticals, ... (NA) | 16-Feb-21 | Grant | 11,100 | -- | -- | 30% 37.42K to 48.52K | |
| 18-Feb-21 7:00 PM View: | Deciphera Pharmaceuticals, ... (NA) | 16-Feb-21 | Market Sale | 132 | $48.87 | $6,450.84 | (< 1%) 48.52K to 48.39K | |
| 11-Dec-20 4:10 PM View: | Deciphera Pharmaceuticals, ... (NA) | 09-Dec-20 | Option Exercise | 207 | $34.43 | $7,127.01 | < 1% 37.21K to 37.42K | |
| 18-Nov-20 7:31 PM View: | Deciphera Pharmaceuticals, ... (NA) | 16-Nov-20 | Option Exercise | 2,697 | $34.43 | $92,857.70 | 8% 34.51K to 37.21K | |
| 06-Oct-20 4:00 PM View: | Deciphera Pharmaceuticals, ... (NA) | 02-Oct-20 | Payment of Exercise | 2,632 | $51.15 | $134,618.00 | (7%) 36.76K to 34.13K | |
| 20-Feb-20 4:10 PM View: | Deciphera Pharmaceuticals, ... (NA) | 18-Feb-20 | Grant | 1,760 | -- | -- | 5% 35.0K to 36.76K | |
| 17-Oct-19 4:35 PM View: | Deciphera Pharmaceuticals, ... (NA) | 15-Oct-19 | Grant | 35,000 | -- | -- | 100% 0 to 35.0K | |
| 04-Apr-18 4:39 PM View: | Acceleron Pharma Inc (XLRN) | 03-Apr-18 | Market Sale (Planned) | 4,600 | $38.43 | $176,772.00 | (6%) 81.87K to 77.27K | (368%) |
| 05-Apr-18 8:07 PM View: | Pulmatrix, Inc. (PULM) | 03-Apr-18 | Purchase | 20,000 | -- | -- | 100% 0 to 20.0K | |
| 04-Jan-18 7:02 PM View: | Acceleron Pharma Inc (XLRN) | 03-Jan-18 | Market Sale (Planned) | 4,633 | $42.71 | $197,868.00 | (5%) 86.5K to 81.87K | (321%) |
| 14-Sep-17 5:02 PM View: | Acceleron Pharma Inc (XLRN) | 12-Sep-17 | Market Sale (Planned) | 18,400 | $38.41 | $706,799.00 | (18%) 104.9K to 86.5K | (368%) |
| 07-Jul-17 4:55 PM View: | Acceleron Pharma Inc (XLRN) | 05-Jul-17 | Option Exercise | 8,000 | $7.12 | $56,960.00 | 7% 112.9K to 120.9K | |
| 07-Jul-17 4:55 PM View: | Acceleron Pharma Inc (XLRN) | 05-Jul-17 | Market Option Sale (Planned) | 8,000 | $32.00 | $256,000.00 | (7%) 120.9K to 112.9K | (462%) |
| 07-Jul-17 4:55 PM View: | Acceleron Pharma Inc (XLRN) | 05-Jul-17 | Market Sale (Planned) | 8,000 | $32.00 | $256,000.00 | (7%) 112.9K to 104.9K | (462%) |
| 14-Mar-17 6:15 PM View: | Acceleron Pharma Inc (XLRN) | 02-Mar-17 | Grant | 7,900 | -- | -- | 8% 105.0K to 112.9K | |
| 06-Jan-17 5:12 PM View: | Acceleron Pharma Inc (XLRN) | 04-Jan-17 | Market Sale (Planned) | 2,000 | $27.46 | $54,916.00 | (2%) 107.0K to 105.0K | (555%) |
| 11-Aug-16 5:28 PM View: | Acceleron Pharma Inc (XLRN) | 10-Aug-16 | Option Exercise | 18,896 | $6.94 | $131,051.00 | 21% 88.1K to 107.0K | |
| 07-Jul-16 4:06 PM View: | Acceleron Pharma Inc (XLRN) | 07-Jul-16 | Option Exercise | 6,000 | $5.28 | $31,680.00 | 7% 82.1K to 88.1K | |
| 06-Jul-16 5:47 PM View: | Acceleron Pharma Inc (XLRN) | 01-Jul-16 | Option Exercise | 14,000 | $4.85 | $67,840.80 | 15% 94.1K to 108.1K | |
| 06-Jul-16 5:47 PM View: | Acceleron Pharma Inc (XLRN) | 01-Jul-16 | Market Option Sale (Planned) | 14,000 | $34.74 | $486,308.00 | (13%) 108.1K to 94.1K | (380%) |
| 06-Jul-16 5:47 PM View: | Acceleron Pharma Inc (XLRN) | 01-Jul-16 | Market Sale (Planned) | 12,000 | $34.74 | $416,835.00 | (13%) 94.1K to 82.1K | (380%) |
| 08-Apr-16 4:02 PM View: | Acceleron Pharma Inc (XLRN) | 07-Apr-16 | Option Exercise | 14,000 | $5.08 | $71,120.00 | 13% 104.02K to 118.02K | |
| 08-Apr-16 4:02 PM View: | Acceleron Pharma Inc (XLRN) | 07-Apr-16 | Market Option Sale (Planned) | 11,920 | $32.00 | $381,440.00 | (10%) 118.02K to 106.1K | (422%) |
| 08-Apr-16 4:02 PM View: | Acceleron Pharma Inc (XLRN) | 07-Apr-16 | Market Sale (Planned) | 12,000 | $32.00 | $384,000.00 | (11%) 106.1K to 94.1K | (422%) |
| 08-Apr-16 4:02 PM View: | Acceleron Pharma Inc (XLRN) | 06-Apr-16 | Market Option Sale (Planned) | 2,080 | $32.00 | $66,560.00 | (2%) 106.1K to 104.02K | (422%) |
| 07-Mar-16 5:15 PM View: | Acceleron Pharma Inc (XLRN) | 03-Mar-16 | Grant | 6,000 | -- | -- | 6% 100.1K to 106.1K | |
| 16-Oct-15 4:41 PM View: | Acceleron Pharma Inc (XLRN) | 15-Oct-15 | Market Sale (Planned) | 4,800 | $23.30 | $111,816.00 | (5%) 106.1K to 101.3K | (617%) |
| 16-Oct-15 4:41 PM View: | Acceleron Pharma Inc (XLRN) | 15-Oct-15 | Market Sale (Planned) | 1,200 | $23.21 | $27,853.00 | (1%) 101.3K to 100.1K | (619%) |
| 18-Sep-15 4:15 PM View: | Acceleron Pharma Inc (XLRN) | 16-Sep-15 | Market Sale (Planned) | 1,600 | $32.81 | $52,493.00 | (1%) 108.1K to 106.5K | (409%) |